Cuproptosis Combined with lncRNAs Predicts the Prognosis and Immune Microenvironment of Breast Cancer

Figure 6

(a) PCA of all genes. (b) Different risks of cuproptosis-related genes. (c) Different risks of cuproptosis-related lncRNAs. (d) Different risks of lncRNA expression PCA. (e) The model predicted survival in different risks. (f) The model predicted progression-free survival in different risks. (g, h) Risk score distribution and survival status of breast cancer patients in different risks.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)